Innoviva, Inc.
DE ˙ DB ˙ US45781M1018
19,20 € ↑0,70 (3,78%)
2026-06-04
DEL PRIS
SecurityDE:HVE / Innoviva, Inc.
InstitutionRhumbline Advisers
Latest Disclosed Ownership199,898 shares
Latest Disclosed Value $ 4,657,605
Rhumbline Advisers reports 0.27% increase in ownership of HVE / Innoviva, Inc.

On May 12, 2026 - Rhumbline Advisers filed a 13F-HR form disclosing ownership of 199,898 shares of Innoviva, Inc. (DE:HVE) valued at $3,997,960 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 199,360 shares of Innoviva, Inc.. This represents a change in shares of 0.27% during the quarter. The current value of the position is $3,838,042 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F INNOVIVA INC COM COM 45781M101 199,898 538 0.27 4,658 16.86 0.0040
2026-02-13 2025-12-31 13F INNOVIVA INC COM COM 45781M101 199,360 5,401 2.78 3,985 12.60 0.0032
2025-11-06 2025-09-30 13F INNOVIVA INC COM COM 45781M101 193,959 7,875 4.23 3,540 -5.32 0.0028
2025-08-12 2025-06-30 13F INNOVIVA INC COM COM 45781M101 186,084 7,954 4.47 3,738 15.76 0.0032
2025-05-29 2025-03-31 13F/A-1 INNOVIVA INC COM COM 45781M101 178,130 -9,188 -4.91 3,229 -0.62 0.0030
2025-04-08 2025-03-31 13F INNOVIVA INC COM COM 45781M101 178,130 -9,188 3,229 0.0030
2025-05-29 2024-12-31 13F/A-1 INNOVIVA INC COM COM 45781M101 187,318 3,931 2.14 3,250 -8.25 0.0029
2025-01-30 2024-12-31 13F INNOVIVA INC COM COM 45781M101 187,318 3,931 3,250 0.0029
2024-11-12 2024-09-30 13F INNOVIVA INC COM COM 45781M101 183,387 -21,395 -10.45 3,541 5.45 0.0032
2024-08-01 2024-06-30 13F INNOVIVA INC COM COM 45781M101 204,782 -3,325 -1.60 3,358 5.90 0.0032
2024-05-09 2024-03-31 13F INNOVIVA INC COM COM 45781M101 208,107 170,952 460.10 3,172 2,014.00 0.0030
2024-02-08 2023-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 37,155 9,197 32.90 150 100.00 0.0002
2024-02-08 2023-12-31 13F INNOVIVA INC COM COM 45781M101 208,536 3,242 3,345 0.0035
2023-11-09 2023-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 27,958 661 2.42 75 -70.47 0.0001
2023-11-09 2023-09-30 13F INNOVIVA INC COM COM 45781M101 205,294 -2,154 2,667 0.0031
2023-08-08 2023-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 27,297 1,475 5.71 255 0.0003
2023-08-08 2023-06-30 13F INNOVIVA INC COM COM 45781M101 207,448 10,717 2,641 0.0030
2023-05-11 2023-03-31 13F THESEUS PHARMACEUTICALS COM 88369M101 25,822 820 3.28 0 -100.00 0.0003
2023-05-11 2023-03-31 13F INNOVIVA INC COM COM 45781M101 196,731 10,670 2 0.0027
2023-02-14 2022-12-31 13F THESEUS PHARMACEUTICALS COM 88369M101 25,002 154 0.62 125 -13.19 0.0002
2023-02-14 2022-12-31 13F INNOVIVA INC COM COM 45781M101 186,061 2,461 2,465 0.0033
2022-11-10 2022-09-30 13F THESEUS PHARMACEUTICALS COM 88369M101 24,848 1,443 6.17 144 11.63 0.0002
2022-11-10 2022-09-30 13F INNOVIVA INC COM COM 45781M101 183,600 3,767 2,132 0.0032
2022-08-11 2022-06-30 13F THESEUS PHARMACEUTICALS COM 88369M101 23,405 -139,383 -85.62 129 -95.90 0.0002
2022-08-11 2022-06-30 13F INNOVIVA INC COM COM 45781M101 179,833 17,045 2,654 0.0039
2022-05-12 2022-03-31 13F INNOVIVA INC COM COM 45781M101 162,788 -16,531 -9.22 3,150 1.84 0.0041
2022-02-10 2021-12-31 13F INNOVIVA INC COM COM 45781M101 179,319 -5,812 -3.14 3,093 -0.03 0.0038
2021-11-12 2021-09-30 13F INNOVIVA INC COM COM 45781M101 185,131 -42,276 -18.59 3,094 1.44 0.0042
2021-08-05 2021-06-30 13F INNOVIVA INC COM COM 45781M101 227,407 12,746 5.94 3,050 18.91 0.0040
2021-05-06 2021-03-31 13F INNOVIVA INC COM COM 45781M101 214,661 10,901 5.35 2,565 1.58 0.0035
2021-02-10 2020-12-31 13F INNOVIVA INC COM COM 45781M101 203,760 10,380 5.37 2,525 24.94 0.0035
2020-11-12 2020-09-30 13F INNOVIVA INC COM COM 45781M101 193,380 -20,520 -9.59 2,021 -32.41 0.0032
2020-08-13 2020-06-30 13F INNOVIVA INC COM COM 45781M101 213,900 -6,126 -2.78 2,990 15.53 0.0050
2020-05-06 2020-03-31 13F INNOVIVA INC COM COM 45781M101 220,026 4,624 2.15 2,588 -15.15 0.0054
2020-02-05 2019-12-31 13F INNOVIVA INC COM COM 45781M101 215,402 9,529 4.63 3,050 40.55 0.0051
2019-10-23 2019-09-30 13F INNOVIVA INC COM COM 45781M101 205,873 3,547 1.75 2,170 -26.34 0.0040
2019-08-14 2019-06-30 13F INNOVIVA INC COM COM 45781M101 202,326 3,453 1.74 2,946 5.59 0.0055
2019-05-01 2019-03-31 13F INNOVIVA INC COM COM 45781M101 198,873 1,632 0.83 2,790 -18.94 0.0054
2019-01-31 2018-12-31 13F INNOVIVA INC COM COM 45781M101 197,241 31,815 19.23 3,442 36.53 0.0075
2018-11-07 2018-09-30 13F INNOVIVA INC COM COM 45781M101 165,426 -5,132 -3.01 2,521 7.09 0.0049
2018-08-06 2018-06-30 13F INNOVIVA INC COM COM 45781M101 170,558 -1,078 -0.63 2,354 -17.72 0.0047
2018-05-02 2018-03-31 13F INNOVIVA INC COM COM 45781M101 171,636 131 0.08 2,861 17.54 0.0060
2018-02-09 2017-12-31 13F INNOVIVA INC COM COM 45781M101 171,505 19,735 13.00 2,434 13.58 0.0049
2017-11-06 2017-09-30 13F INNOVIVA INC COM COM 45781M101 151,770 1,019 0.68 2,143 11.04 0.0047
2017-08-02 2017-06-30 13F INNOVIVA INC COM COM 45781M101 150,751 -6,037 -3.85 1,930 -10.98 0.0044
2017-05-02 2017-03-31 13F INNOVIVA INC COM COM 45781M101 156,788 44,662 39.83 2,168 80.67 0.0051
2017-01-27 2016-12-31 13F INNOVIVA INC COM COM 45781M101 112,126 20,028 21.75 1,200 18.58 0.0030
2016-11-08 2016-09-30 13F INNOVIVA INC COM COM 45781M101 92,098 1,370 1.51 1,012 5.97 0.0028
2016-08-11 2016-06-30 13F INNOVIVA INC COM COM 45781M101 90,728 -3,475 -3.69 955 -19.48 0.0028
2016-05-02 2016-03-31 13F INNOVIVA COM 45781M101 94,203 1,465 1.58 1,186 21.39 0.0037
2016-02-03 2015-12-31 13F THERAVANCE INC US COM 88338T104 92,738 5,810 6.68 977 56.57 0.0031
2015-11-04 2015-09-30 13F THERAVANCE INC US COM 88338T104 86,928 4,387 5.31 624 -58.18 0.0021
2015-08-04 2015-06-30 13F THERAVANCE INC US COM 88338T104 82,541 -3,170 -3.70 1,492 10.76 0.0048
2015-05-12 2015-03-31 13F THERAVANCE INC US COM 88338T104 85,711 10,905 14.58 1,347 27.20 0.0039
2015-02-06 2014-12-31 13F THERAVANCE INC US COM 88338T104 74,806 -1,895 -2.47 1,059 -19.22 0.0031
2014-11-12 2014-09-30 13F THERAVANCE INC US COM 88338T104 76,701 -3,320 -4.15 1,311 -44.99 0.0039
2014-08-06 2014-06-30 13F THERAVANCE INC US COM 88338T104 80,021 15,499 24.02 2,383 19.39 0.0070
2014-05-06 2014-03-31 13F THERAVANCE INC US COM 88338T104 64,522 -3,050 -4.51 1,996 -17.14 0.0059
2014-02-03 2013-12-31 13F THERAVANCE INC US COM 88338T104 67,572 -5,860 -7.98 2,409 -19.78 0.0071
2013-11-05 2013-09-30 13F THERAVANCE INC US COM 88338T104 73,432 -9,276 -11.22 3,003 -5.77 0.0093
2013-08-07 2013-06-30 13F THERAVANCE INC US COM 88338T104 82,708 82,708 3,187 0.0102
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.